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Periosteal expansion osteogenesis using an innovative, shape-memory polyethylene  
terephthalate membrane: An experimental study in rabbits 
Abstract 
Background: Periosteal expansion osteogenesis (PEO) results in the formation of new bone in 
the gap between periosteum and original bone. The purpose of this study is to evaluate the 
use of a polyethylene terephthalate (PET) membrane as an activation device. 
Methods: A dome-shaped PET membrane coated with hydroxyapatite (HA) /gelatin on the 
inner side was inserted between the elevated periosteum and bone at the rabbit calvaria. In 
the experimental group, the membrane was pushed, bent, and attached to the bone surface 
and fixed with a titanium screw. In control group, the membrane was only inserted and fixed 
with titanium screw at original shape under the periosteum. After 7 days, the screw was 
removed and the mesh was activated in the experimental group. Three animals per group with 
or without setting a latency period for activation were sacrificed at 3 and 5 weeks after 
surgery. Bone formation was evaluated via micro-computed tomography and determined by 
histomorphometric methods and histological evaluation. 
Results: No PET membrane-associated complications were observed during this study. The 
quantitative data by the area and the occupation of newly formed bone indicated that the 
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experimental group had a higher volume of new bone than the control group at 3 weeks after 
surgery. Histologically, bone formation progressed to areas adjacent to the cortical 
perforations; many sinusoidal vessels ran from the perforations to overlying fibrous tissue via 
the new bone. No bone or obvious inflammatory cells were observed over the membrane. 
Conclusion: The PET membrane has biocompatible device for PEO that induces a natural 
osteogenic response at the gap between the original bone and periosteum.  
 
1. Introduction 
Dental implant placement is standard after tooth loss, and alveolar bone grafting is usually 
performed if the bone volume is inadequate (Sethi and Kaus, 2001; Triplett and Schow,1996). 
However, this is associated with donor site morbidity. In addition, the amount of bone that 
can be grafted may be small if soft tissue surrounding the wound has engaged in primary 
closure. Thus, other augmentation methods are needed. Distraction osteogenesis (DO) 
(Ilizarov et al., 1989) exploits biological healing; bone regeneration occurs in a gap between 
segments that are gradually separated (Chin and Toth, 1996; Takahashi et al., 2004; 
Yamauchi et al., 2013a,b). Periosteal distraction or elevation (without corticotomy) may also 
be employed (Kessler et al.,2007; Schmidt at al., 2002). Application of tensile strain to the 
periosteum causes tenting, and new bone grows in the space created. Corticotomy, bone 
harvesting, an allograft, or a bone substitute is required. Our previous studies reported a 
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method of periosteal expansion osteogenesis (PEO) using a beta-tricalcium phosphate 
(β-TCP) block (Yamauchi et al., 2008, 2010). It promotes bone formation without 
autogenous grafting or osteotomy. However, as is true of DO, the method requires external 
mechanical activation in the form of a turning device that penetrates the mucosa or skin. Soft 
tissue augmentation at the site of penetration may trigger wound dehiscence, exposing the 
device and causing infection. For PEO, an ideal device should be small, easy to implant, 
biocompatible, and mechanically strong. Previously, a nickel-titanium (Ni-Ti) shape-memory 
alloy (SMA) device was used to perform PEO (Yamauchi et al., 2013a,b, 2016). The innate 
elasticity removed the need for manual activation. Timed release of bioresorbable materials 
obviated any requirement for secondary surgical intervention. However, it is difficult to 
shape the alloy to individual bone morphologies, the material is expensive, and there is risk 
for an allergic reaction. Polyethylene terephthalate (PET) is a useful alternative that has been 
used to form artificial blood vessels and ligaments (Ma et al., 2005; Krudwig et al., 2002). In 







2. Materials and Methods 
 2.1 Animals 
 Twelve Japanese white rabbits (males, 3–3.5 kg) were used. The study protocol was 
approved by the Animal Care and Use Committee of Tohoku University, Sendai, Japan, in 
accordance with local laws and regulations (approval no. 2018DnA-025). 
 2.2 PET membrane 
 PET sheets 125 µm in thickness were obtained from Toyobo Co. Ltd., Osaka, Japan. Sheets 
are non-permeable, pore-free PET film (Fig.1) (Furusawa et al., 2012). Hydroxyapatite (HA) 
powder was prepared by adding a phosphoric acid solution (0.1mol/dm3) to a suspension of 
Ca(OH)2 to the stoichiometric ratio of HA (Ca/P=1.67 in mole). The resulting precipitate, 
low-crystalline HA, was collected by freeze-drying. An aqueous slurry containing 10 wt% 
HA powder and 1 wt% gelatin was prepared and applied to one side of the PET sheets using 
a film applicator of aperture 90 µm. After drying at ambient temperature, the sheets were 
vacuum-dried at 393K for 3 h to promote thermal cross-linking of the gelatine, ensuring tight 
adhesion of the coated layer to the PET substrate. A small portion of a coated sheet was 
subjected to scanning electron microscopy (e-SEM, Shimadzu Rika Corp., Tokyo Japan) 
(Fig.2-a,b). Before implanting the PET sheets into the animals, the sheets were cut into 
rectangles 8 mm in width and 15 mm in length and pre-curved by heating and cooling the 
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individual sheets to fix an appropriate curvature as shown in Fig.2, utilizing the thermoplastic 
nature of PET. 
2.3 Surgery 
 All rabbits were anesthetised via intramuscular administration of ketamine hydrochloride 
(60mg/kg Ketalar, Sankyo, Tokyo, Japan) followed by diazepam (5 mg) and atropine sulphate 
(0.5 mg), without endotracheal intubation. In addition, 1.8 mL local aesthetic (2% xylocaine 
and epinephrine 1:80,000, Dentply Sankin, Tokyo, Japan) solution was injected. All surgery 
was performed under standard sterile conditions. 
 The rabbits were divided into four groups: C1 (control; analysed 3 weeks postoperatively, 
n=3), C2 (control; analysed 5 weeks postoperatively, n=3), P1 (coated; analysed 3 weeks 
postoperatively, n=3), and P2 (coated; analysed 5 weeks postoperatively, n=3). Each head 
was shaved and an arcuate incision was created with a scalpel to reveal the periosteum. A 
second arcuate incision was used to elevate the periosteum. In the control groups, the PET 
membrane was inserted between the periosteum and bone and the periosteum and skin were 
repositioned and sutured with 5–0 polyamide thread (GC, Tokyo, Japan). In the P1/2 groups, 
the PET membrane was inserted between the elevated periosteum and bone, fixed with 
titanium screws (1.4mm in diameter, 3mm in length; Jeil Medical corp. Korea), and then the 
tissues were brought into close contact. After screw fixation, the periosteum and skin were 
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sutured with 5–0 polyamide thread (Fig.3,4-a-d). Water and food were available ad libitum. 
One week after surgery, animals of the P1/2 groups were re-anaesthetised and the screws 
were loosened. These rabbits were sacrificed 3 or 5 weeks later using a lethal dose of 
thiopental sodium. Control rabbits were sacrificed 3 or 5 weeks after initial surgery. All 
cranial bones were removed and fixed for 14 days in 10% (v/v) paraformaldehyde.  
2.4 Tissue preparation and histological evaluation 
 Bone formation was evaluated via micro-computed tomography (µCT) (Comscantechno, 
Co., Ltd., Yokohama, Japan) (65 μA and 80 kV). The extent of osteogenesis was evaluated in 
three dimensions. The volume of new bone was measured using Image J ver. 1.52 software 
(NIH, Bethesda, MD, USA). First, we performed areal evaluation of five arbitrary sections 
exhibiting bone formation. The total area under the PET membrane was the expanded volume 
(EV). The area of mineralised tissue in the EV was the total bone volume (TBV). The 
TBV/EV ratio was a measure of new bone growth. The ratio was calculated for each of the 
five sections and the average was derived. Next, all specimens were decalcified in PBS with 
10% (w/v) EDTA at room temperature for 60 days, dehydrated in ethanol, cleared in xylene, 
and embedded in paraffin. Sagittal sections (5 μm in thickness) were prepared and mounted 
on glass slides. Haematoxylin and Eosin and Elastica and Masson staining were performed to 
allow of morphological evaluation of new bone in the gap between the PET membrane and 
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the surface of original bone. 
2.5 Statistical analyses 
 Normality and homogeneity were analysed using measures of variance. The unpaired 
Student’s t-test was employed to compare areas of newly formed bone, TBV/EV ratios, and 
TBVs. A P-value < 0.05 was taken to indicate statistical significance. All analyses were 
performed using SPSS Statistic (version 27) for Windows® (IBM Corp., Armonk, NY, USA). 
 
3. Results 
No PET membrane-associated complications (such as infection) were observed in any 
animal at any point. In the experimental groups, all membranes returned to their near- 
original shapes; the final distance from the membrane peak to original bone was about 3 mm. 
3.1 μCT and histomorphometric analyses 
 New bone was less radiopaque than original bone in μCT. New bone was observed on top of 
the original cortical bone (under the PET membrane); the EV was almost filled with soft 
tissue. In all groups, new bone was observed where dome shaped PET membrane legs 
contacted original bone, with central dents in some cases (Fig.5). From weeks 3 to 5, bone 
volume increased in the control groups and decreased slightly in the experimental groups. 
The difference between the control and 3-week experimental groups was significant 
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(p<0.05); that between the control and 5-week experimental groups was not (p>0.05). The 
mean TBV/EV ratios are shown in Table 1. The values were higher in the P1/2 groups than 
the control groups, and greater in the P2 than the P1 group. 
3.2 Histological findings 
3.2.1 Control groups 
 No bone or inflammatory cells were evident on top of the membrane. In the C1/2 groups, 
most of the space under the periosteum created by the PET membrane was occupied by 
fibrous tissue without obvious inflammatory cells (Fig.6). Osteogenesis was largely confined 
to the sides where the PET membrane was attached to original bone; new bone was 
connected to original bone via (also new) trabecular bone (Fig.7). Many sinusoidal vessels 
were evident in the centre of the expanded area. In the C2 group, the contours of the 
dome-shaped osteogenic layer were more obvious on the surface of original bone than in the 
C1 group.  
3.2.2 Experimental groups 
 As in the control groups, fibrous tissue and new bone were evident between the extended 
periosteum and existing bone (Fig.7). No bone or obvious inflammatory cells were observed 
over the membrane. Bone formation progressed to areas adjacent to the cortical perforations; 
many sinusoidal vessels ran from the perforations to overlying fibrous tissue via the new 
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bone (Fig.8). Layers of osteoblasts were evident on the surface of new bone; these were 
absent in the control groups (Fig.9). At the sides where the PET membrane contacted original 
bone, new bone followed the shape of the membrane, sometimes connected to the inner side 
of the membrane. No bone directly contacted the centre of the membrane; only fibrous tissue 
with a few sinusoidal vessels was found in this region. Elastica and Masson staining revealed 
new bone maturation in the 5-week (but not the 3-week) group, as evidence by discolouration 
and the disappearance of the interface between new and original bone (Fig.10). 
 
4. Discussion 
New bone formation was evaluated in the gap between original bone and a periosteum 
expanded by a PET membrane in this study. The membrane reverts to its own original shape, 
as do all shape-memory materials. The membrane was positioned under the skin/mucosa, and 
did not observe any wound dehiscence, infection, or poor bone formation around the device. 
New bone formed on original bone, as after PEO (Yamauchi et al., 2016). There was no 
inflammation around the membrane, and no new bone developed at either side of the 
membrane. The membrane raised the periosteum to create a space between the periosteum 




 Compared to Ni-Ti, PET is easier to handle; it is simple to adjust the size and shape 
intraoperatively. In addition, it can be coated to induce an osteogenic response. Furusawa et 
al. promoted osteogenesis by coating the membrane with calcium phosphate on the side 
opposed to original bone (Furusawa et al., 2012). In addition, as PET is hydrophobic, it 
adheres less to surrounding tissue than does Ni-Ti, and thus is simpler to remove after 
consolidation. It is also less allergenic than Ni-Ti and other metal devices.  
Bone augmentation using PET has been little studied. Maruyama et al. reported a “casing 
method” using PET capsules containing bone substitutes (Maruyama et al., 2018). The PET 
case was fit to the original bone surface, and thus the bone substitutes were completely 
isolated from surrounding soft tissue (including the periosteum). Bone regeneration 
commenced at the original bone surface, as we report here; however, regeneration differed in 
that osteogenesis was based on the osteoconductive reaction of the bone substitutes HA and 
β-TCP. Many sinusoidal vessels originating from original bone and multinucleated cells were 
evident on the surface of the bone substitute. They also emanated from the area of cortical 
perforation and ran to new bone; a few multinucleated cells were evident in the gap between 
the PET membrane and original bone. No inflammatory cells were observed in the mucosa 
covering the case. PET is biocompatible and thus suitable for alveolar bone augmentation. 
Taken together that previous study and our current work indicate that PET effectively aids 
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bone augmentation, serving as a new interface between bone and soft tissue. 
In the experimental groups, the TBV/EV ratios were 27.5% and 27.6% in the 3- and 5-week 
groups, respectively, close to the 21.9% and 36.0% of previous Ni-Ti experiments (Yamauchi 
et al., 2016) but in contrast with the 6% and 24% reported in 4- and 6-week groups of rabbits 
in which Ti mesh had been implanted in parietal bone (Zakaria et al., 2012 a,b). According to 
the TBV values, the bone areas decreased from 2.76 and 2.04 mm2 as the duration of 
periosteal extension increased. Zakaria et al. (Zakaria et al., 2020) used periosteal extension 
periods of 8 and 16 weeks when evaluating a shape-memory device composed of Ni-Ti and 
silicon film in parietal bone of rabbits. The longer the period, the smaller the TBV/EV ratio 
(Zakaria et al., 2020). Irrespective of the device used, progress was initially rapid and then 
decreased. 
 Periosteal DO can be divided into periods of latency, activation, and consolidation (Oda et 
la., 2009; Scmidt et al., 2002; Sencimen at al., 2007). In our study, the control groups lacked 
latency periods, the membrane was not crimped to bone, and the periosteum was immediately 
extended. Thus, the device was not sufficiently protected by the periosteum, the temporary 
healing of soft tissue was poor, and space creation was inadequate (Yamauchi et al., 2016; 
Saulacic et al., 2015). In the experimental groups, 1 week elapsed from device implantation 
to commencement of extension and the periosteum was slowly elevated, improving space 
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creation. Previous studies on adult animals have found that immediate periosteal elevation 
does not allow new bone formation on original bone (Kostopolus and Karring et al., 1995; 
Weng et al., 2000). It is important to slowly elevate the periosteum after waiting for some 
time.  
Histologically, many sinusoidal vessels running from the original cortical perforation to 
fibrous tissue over new bone. Osteoblasts play major roles in new bone formation; these cells 
are derived from the periosteum, endosteum, and undifferentiated pluripotent mesenchymal 
cells of the bone marrow (Nijweide et al., 1986). Vascularisation from original bone marrow 
drives early bone regeneration. The osteogenic response was initiated by the HA on the inner 
side of the membrane, and osteoblasts differentiated in the vascularised area. In the 
experimental groups, the distance from the bone surface to the membrane was smaller than 
that of the control groups, indicating that the initial osteogenic reaction was higher than in the 
controls. The extent of new bone was greater in the 5-week test group than in the control 
group. The PET membrane created space for fibrous tissue ingrowth, which may have 
compromised the osteogenic response. Thus, we found no significant difference between 
control and experimental groups in the 5-week group. Both membrane design and expansion 
speed (elasticity) affect the extent of bone regeneration. 
 During bone formation via PEO, expansion speed is important. In this work, however, the 
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periosteum expanded immediately after the fixing screws were removed; the speed could not 
be adjusted or controlled. Using one type of PET membrane in this study, this material has 
never been employed for periosteal DO and we thus lack data on the optimal expansion speed. 
Membrane elasticity, thickness, and design should be investigated in future studies. 
New bone was observed in the gap between the PET membrane and original bone, without 
any bone substitute. PET is biocompatible and easy to use. We induced a natural osteogenic 
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Figure legends 
Fig.1 images of shape memory membrane (PET membrane). 
 
Fig.2(a) SEM image of PET membrane. From left: PET surface, gelatin layer, calcium 
phosphate layer (×200). 
 
Fig.2(b) SEM image of PET membrane (×1,000). 
Fig.3 Schematic drawing showed PET membrane technique, A) PET membrane was inserted 
between the periosteum and fix with titanium screw. B) PET membrane is moved to the 
original shape and periosteum was expanded by PET membrane. 
 
Fig.4 After the periosteum was elevated and the bone surface was indicated, decortication 
was performed (a). The PET membrane was inserted under the periosteum (b), fixed with a 
screw (c), the periosteum was reposition, and sutured (d). 
 
Fig.5 In 3 (A:C1) and 5 (B:C2) -week groups, soft focused X-ray CT image showing the new 
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bone (yellow arrows) is observed, which rises like a dome above the existing bone under the 
periosteum.  
 
Fig.6 Comparison of new bone mass in C1 (A) and P1 (B) groups. The P1 group has more 
new bone (n) over the existing bone (o). In C1, more fibrous tissue (f) was ovserved. Bars 
indicate 0.5mm, Elastica and Masson staining. 
 
Fig.7 Newly formed bone (n) in C1 (A) and P1 (B) were observed at side where the PET 
membrane (p) attached to the original bone surface (o). Bars equal 0.1mm, 
Hematoxylin-Eosin staining. 
 
Fig.8 New bone (n) in P2 is observed between PET membrane (p) and the existing bone (o), 
and a large number of sinusoidal vessels (v) continuous from the bone marrow of the existing 
bone into the new bone (black arrow) can be confirmed. Fibrous tissue (f) can be observed 
above the new bone. The bar indicates 0.1mm, Elastica and Masson staining. 
 
 
Fig.9 An array of osteoblasts in P1 is observed on the bottom of the fibrous tissue on the side 
of the existing bone (black arrows). These are considered to be involved in bone formation in 
P2, Bar equal 0.1mm, Hematoxylin-Eosin staining. 
 
Fig.10 Comparing the Elastica and Masson staining of new bone, the 5-weeks group (B) 
showed more red (more mature bone tissue) staining than the 3-week group (A) (black arrow). 
Bars equal 0.1mm. 
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